tiprankstipranks
Trending News
More News >
Opus Genetics (IRD)
NASDAQ:IRD
US Market

Opus Genetics (IRD) Financial Statements

Compare
1,236 Followers

Opus Genetics Financial Overview

Opus Genetics's market cap is currently $133.10M. The company's EPS TTM is $-0.25; its P/E ratio is -1.19; Opus Genetics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 10.99M$ 19.05M$ 39.85M$ 589.00K$ 0.00
Gross Profit$ 10.99M$ 19.05M$ 39.85M$ 589.00K$ 0.00
Operating Income$ -62.07M$ -10.56M$ 18.23M$ -22.70M$ -19.97M
EBITDA$ -57.52M$ -9.97M$ 18.22M$ -56.69M$ -17.77M
Net Income$ -57.53M$ -9.99M$ 17.89M$ -56.69M$ -24.62M
Balance Sheet
Cash & Short-Term Investments$ 30.32M$ 50.52M$ 42.68M$ 24.75M$ 16.40M
Total Assets$ 36.86M$ 53.95M$ 48.99M$ 26.08M$ 17.68M
Total Debt$ 0.00$ 0.00$ 0.00$ 538.00K$ 0.00
Net Debt$ -30.32M$ -50.50M$ -42.63M$ -24.00M$ -16.40M
Total Liabilities$ 30.14M$ 4.04M$ 2.75M$ 3.85M$ 31.15M
Stockholders' Equity$ 6.72M$ 49.91M$ 46.24M$ 22.22M$ -13.47M
Cash Flow
Free Cash Flow$ -25.58M$ -1.11M$ 14.31M$ -19.37M$ -6.80M
Operating Cash Flow$ -25.58M$ -1.11M$ 14.31M$ -19.37M$ -6.80M
Investing Cash Flow$ 1.21M$ 0.00$ 0.00$ -100.00K$ 539.00K
Financing Cash Flow$ 4.19M$ 8.98M$ 3.79M$ 27.61M$ 21.12M
Currency in USD

Opus Genetics Earnings and Revenue History

Opus Genetics Debt to Assets

Opus Genetics Cash Flow

Opus Genetics Forecast EPS vs Actual EPS